Skip to main content
Top
Published in: BMC Geriatrics 1/2017

Open Access 01-12-2017 | Research Article

Association between traditional cardiovascular risk factors and mortality in the oldest old: untangling the role of frailty

Authors: Bert Vaes, David Depoortere, Gijs Van Pottelbergh, Catharina Matheï, Joana Neto, Jan Degryse

Published in: BMC Geriatrics | Issue 1/2017

Login to get access

Abstract

Background

To date, there is no consensus regarding cardiovascular risk management in the very old. Studies have shown that the relationship between traditional cardiovascular risk factors and mortality is null or even inverted within this age group. This relationship could be modified by the presence of frailty. This study was performed to examine the effect of frailty on the association between cardiovascular risk factors and mortality in the oldest old.

Methods

The BELFRAIL study is a prospective, observational, population-based cohort study of 567 subjects aged 80 years and older. Data on cardiovascular risk factors were recorded. Frailty was assessed using three different models: the Groningen Frailty Indicator, Fried and Puts models. Participants were considered robust if they were ‘not frail’ according to all three models, and frail if they met the frailty criteria for one of the three models. The follow-up data on mortality and cause of death were registered.

Results

No cardiovascular risk factor was associated with mortality in subjects with and without cardiovascular disease. The presence of frailty was a strong risk factor for mortality [HR: 2.5, 95%CI: (1.9–3.2) for all-cause mortality; HR: 2.2, 95%CI: (1.4–3.4) for cardiovascular mortality]. In robust patients, a history of cardiovascular disease increased the risk for mortality [HR: 1.7, 95%CI: (1.1–2.5) for all-cause mortality; HR: 2.2, 95%CI: (1.2–3.9) for cardiovascular mortality]. In frail patients, there was no association between any of the traditional risk factors and mortality.

Conclusions

Traditional cardiovascular risk factors were not associated with mortality in very old subjects. Frailty was shown to be a strong risk factor for mortality in this age group. However, frailty could not be used to identify additional subjects who might benefit more from cardiovascular risk management.
Appendix
Available only for authorised users
Literature
1.
go back to reference Prince MJ, Wu F, Guo Y, Guttierrez Robledo LM, O’Donnell M, Sullivan R, et al. The burden of disease in older people and implications for health policy and practice. Lancet. 2014;385:549–62.CrossRefPubMed Prince MJ, Wu F, Guo Y, Guttierrez Robledo LM, O’Donnell M, Sullivan R, et al. The burden of disease in older people and implications for health policy and practice. Lancet. 2014;385:549–62.CrossRefPubMed
2.
go back to reference Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, et al. European cardiovascular disease statistics. Brussels: European Heart Network; 2017. Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, et al. European cardiovascular disease statistics. Brussels: European Heart Network; 2017.
3.
go back to reference Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37:3232–45.CrossRefPubMed Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37:3232–45.CrossRefPubMed
4.
go back to reference Andrawes WF, Bussy C, Belmin J. Prevention of cardiovascular events in elderly people. Drugs Ageing. 2005;22:859–76.CrossRef Andrawes WF, Bussy C, Belmin J. Prevention of cardiovascular events in elderly people. Drugs Ageing. 2005;22:859–76.CrossRef
5.
go back to reference Alhusban A, Fagan SC. Secondary prevention of stroke in the elderly: a review of the evidence. Am J Geriatr Pharmacother. 2011;9:143–52.CrossRefPubMed Alhusban A, Fagan SC. Secondary prevention of stroke in the elderly: a review of the evidence. Am J Geriatr Pharmacother. 2011;9:143–52.CrossRefPubMed
6.
go back to reference van Bemmel T, Gussekloo J, Westendorp RG, Blauw GJ. A population-based prospective study, no association between high blood pressure and mortality after age 85 years. J Hypertens. 2006;24:287–92.CrossRefPubMed van Bemmel T, Gussekloo J, Westendorp RG, Blauw GJ. A population-based prospective study, no association between high blood pressure and mortality after age 85 years. J Hypertens. 2006;24:287–92.CrossRefPubMed
7.
go back to reference Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, Schron EB, Lindholm LH, Fagard R, et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens. 2010;28:1366–72.CrossRefPubMed Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, Schron EB, Lindholm LH, Fagard R, et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens. 2010;28:1366–72.CrossRefPubMed
8.
go back to reference Newman AB, Gottdiener JS, Mcburnie MA, Hirsch CH, Kop WJ, Tracy R, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci. 2001;56:M158–66.CrossRefPubMed Newman AB, Gottdiener JS, Mcburnie MA, Hirsch CH, Kop WJ, Tracy R, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci. 2001;56:M158–66.CrossRefPubMed
9.
go back to reference Muller M, Smulders YM, de Leeuw PW, Stehouwer CD. Treatment of hypertension in the oldest old. A critical role for frailty? Hypertension. 2014;63:433–41.CrossRefPubMed Muller M, Smulders YM, de Leeuw PW, Stehouwer CD. Treatment of hypertension in the oldest old. A critical role for frailty? Hypertension. 2014;63:433–41.CrossRefPubMed
10.
go back to reference Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults. The impact of frailty. Arch Intern Med. 2012;172:1162–8.CrossRefPubMedPubMedCentral Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults. The impact of frailty. Arch Intern Med. 2012;172:1162–8.CrossRefPubMedPubMedCentral
11.
go back to reference Post Hospers G, Smulders YM, Maier AB, Deeg DJ, Muller M. Relation between blood pressure and mortality risk in an older population: role of chronological and biological age. J Intern Med. 2015;277:488–97.CrossRefPubMed Post Hospers G, Smulders YM, Maier AB, Deeg DJ, Muller M. Relation between blood pressure and mortality risk in an older population: role of chronological and biological age. J Intern Med. 2015;277:488–97.CrossRefPubMed
12.
go back to reference Vaes B, Pasquet A, Wallemacq P, Rezzoug N, Mekouar H, Olivier PA, et al. The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium. BMC Geriatr. 2010;10:39.CrossRefPubMedPubMedCentral Vaes B, Pasquet A, Wallemacq P, Rezzoug N, Mekouar H, Olivier PA, et al. The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium. BMC Geriatr. 2010;10:39.CrossRefPubMedPubMedCentral
13.
go back to reference Steverink N, Slaets JPJ, Schuurmans H, van Lis M. Measuring frailty. Development and testing of the Groningen frailty indicator (GFI). Gerontologist. 2001;41(special issue 1):236–7. Steverink N, Slaets JPJ, Schuurmans H, van Lis M. Measuring frailty. Development and testing of the Groningen frailty indicator (GFI). Gerontologist. 2001;41(special issue 1):236–7.
14.
go back to reference Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype? J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.CrossRefPubMed Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype? J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.CrossRefPubMed
15.
go back to reference Puts MT, Lips P, Deeg DJ. Static and dynamic measures of frailty predicted decline in performance-based and self-reported physical functioning. J Clin Epidemiol. 2005;58:1188–98.CrossRefPubMed Puts MT, Lips P, Deeg DJ. Static and dynamic measures of frailty predicted decline in performance-based and self-reported physical functioning. J Clin Epidemiol. 2005;58:1188–98.CrossRefPubMed
16.
go back to reference van Peet PG, Drewes YM, de Craen AJ, Westendorp RG, Gussekloo J, de Ruijter W. Prognostic value of cardiovascular disease status: the Leiden 85-plus study. Age (Dordr). 2013;35:1433–44.CrossRef van Peet PG, Drewes YM, de Craen AJ, Westendorp RG, Gussekloo J, de Ruijter W. Prognostic value of cardiovascular disease status: the Leiden 85-plus study. Age (Dordr). 2013;35:1433–44.CrossRef
17.
go back to reference de Ruijter W, Westendorp RG, Assendelft WJ, de Elzen WP, de Craen AJ, le Cessie S, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009;a3083:338. de Ruijter W, Westendorp RG, Assendelft WJ, de Elzen WP, de Craen AJ, le Cessie S, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009;a3083:338.
18.
go back to reference van Peet PG, Drewes YM, de Craen AJ, Gussekloo J, de Ruijter W. NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus study. PLoS One. 2013;8:e81400.CrossRefPubMedPubMedCentral van Peet PG, Drewes YM, de Craen AJ, Gussekloo J, de Ruijter W. NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus study. PLoS One. 2013;8:e81400.CrossRefPubMedPubMedCentral
19.
go back to reference Warwick J, Falaschetti E, Rockwood K, Mitnitski A, Thijs L, Beckett N, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the very elderly trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78.CrossRefPubMedPubMedCentral Warwick J, Falaschetti E, Rockwood K, Mitnitski A, Thijs L, Beckett N, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the very elderly trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78.CrossRefPubMedPubMedCentral
Metadata
Title
Association between traditional cardiovascular risk factors and mortality in the oldest old: untangling the role of frailty
Authors
Bert Vaes
David Depoortere
Gijs Van Pottelbergh
Catharina Matheï
Joana Neto
Jan Degryse
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2017
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-017-0626-x

Other articles of this Issue 1/2017

BMC Geriatrics 1/2017 Go to the issue